# Acurx Pharmaceuticals, Inc.: Form 8-K, filed Apr 16, 2026

- Company: [Acurx Pharmaceuticals, Inc.](/companies/acxp.md) (CIK 1736243)
- Form: 8-K
- Filed: 2026-04-16
- Accepted by EDGAR: Apr 16, 2026, 08:14 ET
- Period: 2026-04-15
- Accession: 0001104659-26-044093
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1736243/000110465926044093/tm2611957d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1736243/000110465926044093/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1736243/000110465926044093/tm2611957d1_8k.htm

Filed Apr 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-044093. Last ingested by Listed: Oct 29, 2026, 17:22 ET. No prices; not investment advice.